FDA records identify Guidant Corp. as the applicant on PMA P030005, with a filing address of 4100 Hamline Ave. N, St. Paul, MN. The original approval, dated 2004-01-26, covers the CONTAK RENEWAL models H125 and H120 with the Model 2865 version 1.8 application software, classified under product code NKE as an implantable pulse generator with cardiac resynchronization. The same PMA number later appears on a 2026 supplement for VALITUDE and VISIONIST devices, so the filing spans more than two decades of device generations. The supplied collection holds two linked PMA records, one approval and one 30-day notice. [1][2]

The original CONTAK RENEWAL approval

P030005 was received on 2003-03-24 and approved on 2004-01-26, with a Federal Register notice date of 2004-02-24. The approved device is described as the CONTAK RENEWAL TR pulse generator, and the approval order states that it provides atrial-ventricular tracking modes to help preserve AV synchrony and adaptive-rate pacing for patients who would benefit from adjusted pacing rates concurrent with physical activity. The advisory committee is listed as Cardiovascular, and the expedited review flag is N. [2]

The 2026 VALITUDE and VISIONIST supplement

Supplement S257, a 30-Day Notice received 2026-09-15 and decided 2026-10-03 under decision code OK30, lists VALITUDE (Model U125), VALITUDE X4 (Model U128), VISIONIST (Models U225, U226) and VISIONIST X4 (Model U228). The supplement reason is a process change involving manufacturer, sterilizer, packager or supplier, and the approval order describes an additional acceptance activity for Accolade SL batteries and a changed specification for an existing Accolade EL battery specification. The supplement therefore concerns battery acceptance and specification steps rather than a new device indication. [1]

Product documentation published by Boston Scientific

A Boston Scientific physician's technical manual covers VISIONIST, VISIONIST X4, VALITUDE, VALITUDE X4, INLIVEN, INTUA and INVIVE CRT-P pacemakers under references U225, U226, U228, U125, U128, V284, V285, V282, V283, V182 and V183, and lists Cardiac Pacemakers Incorporated at 4100 Hamline Avenue North, St. Paul, MN, as manufacturer address. A VISIONIST specification sheet describes a RightRate MV sensor and 17 pacing vectors in VISIONIST X4 versus 6 in VISIONIST, and a VALITUDE sheet lists 17 pacing vectors in VALITUDE X4 and 6 in VALITUDE, labeled longevity up to 13.8 years, ImageReady MR-conditional systems for Model U128, and LATITUDE NXT remote monitoring. These are publisher statements about the devices, not FDA findings. [3][4][5]

Performance reporting and filing scope

A Boston Scientific Rhythm Management product performance report, first edition 2026 with data as of 2026-01-05, lists VALITUDE CRT-P Models U125 and U128 and VISIONIST CRT-P Models U225, U226 and U228 among devices covered by its reporting and warranty program. The supplied collection contains two linked PMA records, one OK30 and one APPR, and the smaller record sample likewise holds one of each; these counts describe the retrieved filings only and say nothing about total sales, the full portfolio or safety performance. No recall records were supplied. [6]